Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Preferred Shares: 2012-2013

Historic Preferred Shares for Ocular Therapeutix (OCUL) over the last 2 years, with Dec 2013 value amounting to $8.5 million.

  • Ocular Therapeutix's Preferred Shares was N/A to $8.5 million in Q4 2013 from the same period last year, while for Dec 2013 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $8.5 million for FY2013, which is 64.29% down from last year.
  • As of FY2013, Ocular Therapeutix's Preferred Shares stood at $8.5 million, which was down 64.29% from $23.8 million recorded in FY2012.
  • In the past 5 years, Ocular Therapeutix's Preferred Shares registered a high of $23.8 million during FY2012, and its lowest value of $8.5 million during FY2013.
  • Moreover, its 2-year median value for Preferred Shares was $16.1 million (2012), whereas its average is $16.1 million.
  • Data for Ocular Therapeutix's Preferred Shares shows a maximum YoY plummeted of 64.29% (in 2013) over the last 5 years.
  • Over the past 2 years, Ocular Therapeutix's Preferred Shares (Yearly) stood at $23.8 million in 2012, then tumbled by 64.29% to $8.5 million in 2013.